The emergence of non-secretory multiple myeloma during the non-cytotoxic treatment of essential thrombocythemia: a case report-Reference-Cited by-同舟云学术

The emergence of non-secretory multiple myeloma during the non-cytotoxic treatment of essential thrombocythemia: a case report

Published:2013-09-11 Issue:1 Volume:7 Page:
ISSN:1752-1947
Container-title:Journal of Medical Case Reports
language:en
Short-container-title:J Med Case Reports

Author:

Leković Danijela,Gotić Mirjana,Mitrović Olivera,Radojković Milica,Bila Jelena,Dencic-Fekete Marija,Kraguljac-Kurtović Nada,Peruničić-Jovanović Maja,Čokić Vladan

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/article/10.1186/1752-1947-7-224/fulltext.html

Reference17 articles.

1. Malak S, Labopin M, Saint-Martin C, Bellanne-Chantelot C, Najman A: The French Group of Familial Myeloproliferative Disorders. Long term follow up of 93 families with myeloproliferative neoplasms: life expectancy and implications of JAK2V617F in the occurrence of complications. Blood Cells Mol Dis. 2012, 49: 170-176. 10.1016/j.bcmd.2012.06.004.

2. Björkholm M, Derolf AR, Hultcrantz M, Kristinsson SY, Ekstrand C, Goldin LR, Andreasson B, Birgegard G, Linder O, Malm C, Markerӓrn B, Nisson L, Samuelsson J, Granath F, Landgren O: Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms. J Clin Oncol. 2011, 29: 2410-2415. 10.1200/JCO.2011.34.7542.

3. Radaelli F, Onida F, Rossi FG, Zilioli VR, Colombi M, Usardi P, Calori R, Zanella A: Second malignancies in essential thrombocythemia (ET): a retrospective analysis of 331 patients with long-term follow-up from a single institution. Hematology. 2008, 13: 195-202. 10.1179/102453308X316022.

4. Majhail NS, Lichtin AE: Rare coexistence of multiple myeloma with essential thrombocythemia: report of two cases. Haematologica. 2003, 88: ECR09-

5. Kuroda J, Matsumoto Y, Tanaka R, Kurita K, Kobayashi T, Shimizu D, Kimura S, Ashihara E, Horiike S, Shimazaki C, Taniwaki M: JAK2V617F-positive essential thrombocythemia and multiple myeloma with IGH/CCND1 gene translocation coexist, but originate from separate clones. Acta Haematol. 2008, 120: 177-181. 10.1159/000187645.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case Report: Effects of multiple myeloma therapy on essential thrombocythemia and vice versa: a case of synchronous dual hematological malignancy;Frontiers in Oncology;2023-06-08

2. Extinction of myeloproliferative neoplasm by acquisition of a lymphoid disease: JAK2 V617F and JAK2 exon 12 allele burden disappearance during the follow-up of two patients;Annals of Hematology;2015-11-27